Key Takeaways
- • IAN Angel Fund generated returns of up to 11x for investors through seven portfolio company exits in FY26, producing over ₹40 crore in liquidity, demonstrating strong exit execution in India's early-stage venture ecosystem.
- • Data Sutram, an AI-powered geospatial intelligence startup, delivered the fund's top exit with an 11x multiple and 66% exit IRR, while electric mobility platform Zypp achieved a 10x return with 52% exit IRR; Truemeds (online pharmacy) posted a 71% exit IRR.
- • IAN Angel Fund deployed ₹115 crore across investments in FY26 spanning eight sectors including deep tech, space tech, and biotech, signaling sustained institutional confidence in early-stage innovation-driven ventures as India's startup ecosystem matures.
- • The fund's performance reflects a diversified portfolio strategy combined with active mentorship from the IAN ecosystem's 500-strong investor network, reducing execution risk and enabling portfolio companies to scale through the critical early stages.
- • IAN Angel Fund is a SEBI-registered Category I alternative investment fund offering capital ranging from ₹50 lakh to ₹50 crore, positioning it as a structural player in India's seed and early-growth stage funding landscape amid increasing focus on IP-led and R&D-intensive businesses.
Summary
IAN Angel Fund, the evergreen fund managed by IAN Group, delivered exceptional returns to its investor base during FY26, achieving up to 11x returns through multiple startup exits that generated over ₹40 crore in capital returns. The fund's performance underscores the maturing exit environment for early-stage Indian venture capital, where secondary transactions and strategic acquisitions are providing liquidity to angel and seed-stage investors at meaningful valuations.
The fund's highest-performing exits included Data Sutram, an AI-powered geospatial intelligence platform that delivered an 11x multiple with a 66% exit IRR, and Zypp, an electric mobility startup that generated a 10x return with a 52% exit IRR. Online pharmacy platform Truemeds achieved a 71% exit IRR, the highest among disclosed exits. These results reflect strong execution in sectors aligned with structural growth trends—artificial intelligence, sustainable mobility, and healthtech—where investors are increasingly deploying capital in India.
Beyond exit performance, IAN Angel Fund deployed ₹115 crore in investment activity across eight sectors during FY26, backing deep technology, space technology, biotech, and IP-led businesses. This deployment level reflects sustained confidence from the fund's 500-investor network in early-stage innovation-driven ventures, positioning the fund as a significant source of seed and early-growth capital in an ecosystem that increasingly prioritizes R&D-led businesses and breakthrough intellectual property over traditional business models.
The fund attributes its success to a combination of diversified sector exposure and active mentorship from experienced entrepreneurs and business leaders embedded within the IAN ecosystem. This operational approach has helped portfolio companies reduce execution risk and scale efficiently through critical early stages. As a SEBI-registered Category I alternative investment fund offering capital commitments from ₹50 lakh to ₹50 crore, IAN Angel Fund occupies a strategic position in India's early-stage funding landscape, supporting founders in sectors poised for long-term structural growth as India's innovation economy expands.
The fund's highest-performing exits included Data Sutram, an AI-powered geospatial intelligence platform that delivered an 11x multiple with a 66% exit IRR, and Zypp, an electric mobility startup that generated a 10x return with a 52% exit IRR. Online pharmacy platform Truemeds achieved a 71% exit IRR, the highest among disclosed exits. These results reflect strong execution in sectors aligned with structural growth trends—artificial intelligence, sustainable mobility, and healthtech—where investors are increasingly deploying capital in India.
Beyond exit performance, IAN Angel Fund deployed ₹115 crore in investment activity across eight sectors during FY26, backing deep technology, space technology, biotech, and IP-led businesses. This deployment level reflects sustained confidence from the fund's 500-investor network in early-stage innovation-driven ventures, positioning the fund as a significant source of seed and early-growth capital in an ecosystem that increasingly prioritizes R&D-led businesses and breakthrough intellectual property over traditional business models.
The fund attributes its success to a combination of diversified sector exposure and active mentorship from experienced entrepreneurs and business leaders embedded within the IAN ecosystem. This operational approach has helped portfolio companies reduce execution risk and scale efficiently through critical early stages. As a SEBI-registered Category I alternative investment fund offering capital commitments from ₹50 lakh to ₹50 crore, IAN Angel Fund occupies a strategic position in India's early-stage funding landscape, supporting founders in sectors poised for long-term structural growth as India's innovation economy expands.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.